Global BCG Vaccine Average Price From 3.42 USD/Mg In 2013 To 3.26 USD/Mg In 2017
Warning: date() expects parameter 2 to be long, string given in /www/wwwroot/www.globalinforesearch.com/static/themes/default/info_detail.php on line 32
In the last several years, Global market of BCG Vaccine developed rapidly, with an average growth rate of 5.64%. In 2017, Global revenue of BCG Vaccine is about 300 M USD.
The global average price of BCG Vaccine is in the decreasing trend, from 3.42 USD/mg in 2013 to 3.26 USD/mg in 2017. With the situation of global economy, prices will be in decreasing trend in the following five years.
The type of BCG Vaccine includes Immune BCG and Therapy BCG. The proportion of Therapy BCG in 2017 is about 92%.
BCG Vaccine is widely used in Hospitals and Clinics. The most proportion of BCG Vaccine is sold in Hospitals and the market share in 2017 is about 74%, and the Hospitals have upstream trend.
Japan is the largest supplier of BCG Vaccine, with a production market share nearly 31% in 2017. North America is the second largest supplier of BCG Vaccine Media, enjoying production market share nearly 26% in 2017.
North America region is the largest consumption of BCG Vaccine, with a sales revenue market share nearly 30% in 2017. Europe is the second largest consumer of BCG Vaccine, enjoying sales revenue market share about 27% in 2017.
Market competition is not intense. Merck, Sanofi Pasteur, Japan BCG Lab, China National Biotec, Serum Institute of India, Intervax, GSBPL are the leaders of the industry, and they have been formed in the monopoly position in the industry.